Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PFE | US
0.33
1.24%
Healthcare
Drug Manufacturers - Major
30/06/2024
24/04/2026
27.00
26.69
27.30
26.58
Pfizer Inc. discovers develops manufactures markets distributes and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas including cardiovascular metabolic migraine and women's health under the Eliquis Nurtec ODT/Vydura and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family Nimenrix FSME/IMMUN-TicoVac and Trumenba brands; and COVID-19 prevention and treatment and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz Enbrel Inflectra Eucrisa/Staquis and Cibinqo brands; amyloidosis hemophilia endocrine diseases and sickle cell disease under the Vyndaqel family Oxbryta BeneFIX and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon Medrol Zavicefta Zithromax Vfend and Panzyga brands; and biologics small molecules immunotherapies and biosimilars under the Ibrance Xtandi Inlyta Retacrit Lorbrena and Braftovi brands. In addition the company is involved in the contract manufacturing business. It serves wholesalers retailers hospitals clinics government agencies pharmacies individual provider offices retail pharmacies and integrated delivery systems as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York New York.
View LessStrength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Debt to Equity (> 0.75)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
17.3%1 month
22.6%3 months
23.8%6 months
22.7%-
10.45
1.89
0.79
0.32
41.47
4.12
0.22
9.96B
153.00B
153.00B
5.74
22.40
-98.20
2.10
-2.74
2.23
1.19
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.47
Range1M
2.37
Range3M
3.48
Rel. volume
1.24
Price X volume
991.83M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | BMY | Drug Manufacturers - Major | 58.71 | 119.03B | -0.53% | n/a | 317.39% |
| Sanofi | SNY | Drug Manufacturers - Major | 46.78 | 117.28B | -1.58% | 30.18 | 32.67% |
| GlaxoSmithKline plc | GSK | Drug Manufacturers - Major | 54.44 | 111.97B | -2.14% | 13.16 | 117.89% |
| Hutchison China MediTech Limited | HCM | Drug Manufacturers - Major | 14 | 2.39B | 0.94% | n/a | 11.09% |
| Rockwell Medical Inc | RMTI | Drug Manufacturers - Major | 0.8727 | 27.08M | 1.99% | n/a | 61.18% |
| TherapeuticsMD Inc | TXMD | Drug Manufacturers - Major | 2.19 | 25.26M | 0.46% | n/a | 27.44% |
| NanoViricides Inc | NNVC | Drug Manufacturers - Major | 1.26 | 18.49M | -3.08% | n/a | 0.00% |
| China Pharma Holdings Inc | CPHI | Drug Manufacturers - Major | 0.6293 | 10.80M | 6.64% | n/a | 54.76% |
| ProPhase Labs Inc | PRPH | Drug Manufacturers - Major | 0.13 | 2.48M | 8.51% | n/a | 60.84% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Corning Incorporated | GLW | Electronic Components | 175.89 | 150.51B | 3.77% | 91.49 | 77.44% |
| TE Connectivity Ltd | TEL | Electronic Components | 214.67 | 65.24B | -1.41% | 13.34 | 33.26% |
| CBRE Group Inc | CBRE | Real Estate Services | 148.29 | 45.44B | -0.68% | 42.32 | 79.63% |
| Hubbell Incorporated | HUBB | Electronic Components | 553.07 | 29.69B | -0.86% | 33.79 | 70.46% |
| nVent Electric plc | NVT | Electronic Components | 142.17 | 23.63B | -0.27% | 22.02 | 57.48% |
| KE Holdings Inc | BEKE | Real Estate Services | 16.18 | 20.57B | 2.41% | 42.20 | 28.64% |
| Jones Lang LaSalle Incorporated | JLL | Real Estate Services | 338.56 | 16.07B | 0.28% | 33.62 | 58.74% |
| CoStar Group Inc | CSGP | Real Estate Services | 36.44 | 14.93B | -2.51% | 152.40 | 14.68% |
| Advanced Energy Industries Inc | AEIS | Electronic Components | 387.24 | 14.59B | 1.25% | 44.72 | 87.62% |
| Vicor Corporation | VICR | Electronic Components | 273.53 | 12.33B | 5.15% | 195.43 | 1.39% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 41.47 | 21.06 | Expensive |
| Ent. to Revenue | 4.12 | 5.64 | Cheaper |
| PE Ratio | - | 41.17 | - |
| Price to Book | 1.89 | 11.46 | Cheaper |
| Dividend Yield | 5.74 | 3.27 | Leader |
| Std. Deviation (3M) | 23.80 | 39.12 | Lower Risk |
| Debt to Equity | 0.79 | 1.72 | Cheaper |
| Debt to Assets | 0.32 | 0.31 | Par |
| Market Cap | 153.00B | 200.67B | Emerging |